FilingSEC EDGAR6-K
RedHill Biopharma Divests Talicia Business to Apotex
· SEC accepted
StageDivestiture Completed
Filing content
RedHill Biopharma sold its Talicia business to Apotex for $18 million upfront, with up to $35 million in potential sales-based milestone payments.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…